Literature DB >> 6289456

Radionuclides in the evaluation of urinary obstruction.

S C Scharf, M D Blaufox.   

Abstract

Radionuclide renography and renal scanning techniques are ideally suited to the initial and follow-up evaluation of patients with obstructive uropathy. While other modalities are superior in their ability to provide anatomic information, the radionuclide study yields functional information for each kidney without the necessity to resort to invasive studies. In addition, the Nuclear Medicine study is well suited to the evaluation of obstruction where serial studies often are required because of a lower radiation burden compared to urography. This lower radiation dose is especially important in obstruction because of the recurrent nature of several kinds of obstructive uropathy and because of the high incidence in the pediatric age group. The ability to control urine flow rate during the procedure through dehydration or administration of diuretics is an additional benefit. Increasing availability of computerization of nuclear medicine procedures as well as interest in studies employing physiologic intervention (including the diuresis renogram) have assured an important place for radionuclide studies in the evaluation of patients with urinary obstruction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289456     DOI: 10.1016/s0001-2998(82)80040-8

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  3 in total

1.  Nuclear medicine-important advances in clinical medicine: noninvasive evaluation of obstructive versus nonobstructive uropathy.

Authors:  M G McCalley; P Braunstein
Journal:  West J Med       Date:  1983-11

2.  Evaluation of renal function and morphology with radionuclides.

Authors:  K zum Winkel
Journal:  Eur J Nucl Med       Date:  1984

3.  99mTc-DTPA and 99mTc-DMSA renal gamma imaging in the surveillance of patients with conduit urinary diversion.

Authors:  O Lindell; A Kivisaari; T Lehtonen
Journal:  Eur J Nucl Med       Date:  1986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.